Topics Covered:Principles of Patient-Centered Clinical Radiopharmaceutical Therapy: Quality and Safety —Hyun Kim, MDFor the presentation description, please see the Program tab.

There have been many advancements in terms of treatment and imaging modalities for patients with oligometastatic prostate cancer. Failure to understand these advancements in treatment options leads to lower quality of care delivered by clinicians treating prostate cancer patients.

A multidisciplinary panel discusses the importance of communication and collaboration between multidisciplinary team members, skills that early career attendings often miss the opportunity to experience during their residency training.

The use of SABR is well established in many cancers, however, its application within kidney cancer is relatively new. This is largely due to the historical notion that renal cell carcinoma (RCC) is highly radioresistant.